SCHEMBL783526

SCHEMBL783526

O=C(O)c1c[nH]nc1C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.38
ASPH Q12797 2/20 0.37
HPGD P15428 4/20 0.36
KDM4E B2RXH2 4/20 0.36
KDM4C Q9H3R0 2/20 0.35
ALDH1A1 P00352 4/20 0.34
HSD17B10 Q99714 2/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
ALOX12 P18054 1/20 0.34
KDM5A P29375 2/20 0.34
KDM5B Q9UGL1 2/20 0.34
USP2 O75604 1/20 0.33
CYP2C19 P33261 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPK1 P28482 1/20 0.32
MAP2K4 P45985 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29715790 0.98 NOTUM (0.41) NOTUMASPHHPGDKDM4EKDM4C
SCHEMBL28158873 0.82 ALDH1A1 (0.31) ALDH1A1
SCHEMBL12956800 0.82 ALDH1A1 (0.33) NOTUMKDM4EALDH1A1KMT2AMEN1
SCHEMBL1832559 0.82 MAPK1 (0.39) MAPK1
SCHEMBL727645 0.82 PARP1 (0.37) KDM4EALDH1A1KMT2AMAP2K4
Niacin SCHEMBL28265838 0.81 ALDH1A1 (0.55) ALDH1A1KMT2AMEN1POLBSMN1; SMN2
SCHEMBL1406288 0.80 ALDH1A1 (0.33) NOTUMKDM4CALDH1A1KMT2ACYP1A2
SCHEMBL13373959 0.80 NOTUM (0.38) NOTUMKDM4EKDM4CALDH1A1KMT2A
SCHEMBL3906252 0.79 CFTR (0.43) NOTUMKDM4EALDH1A1KMT2AMAPT
SCHEMBL12450297 0.79 KDM4E (0.31) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119775207-A Morpholine-containing amide compound and preparation method and application thereof 山东农业大学 2025-04-08 CN claimed
CN-118616022-B Application of metal organic framework material in liquid phase separation of hexane isomers 同济大学 2024-11-12 CN claimed
CN-118616022-A Application of metal organic framework material in liquid phase separation of hexane isomers 同济大学 2024-09-10 CN claimed
CN-114957124-B 3- (trifluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof 浙江工业大学 2023-11-07 CN claimed
CN-114957124-A 3- (trifluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof 浙江工业大学 2022-08-30 CN claimed
CN-107929271-A For the sGC stimulants or sGC activator treated the independent of cystic fibrosis and combined with PDE5 inhibitor 阿德弗里奥药品有限责任公司 2018-04-20 CN claimed
CN-106279024-A A kind of xanthine oxidoreductase inhibitors and preparation method and application 华南理工大学 2017-01-04 CN claimed
US-6911453-B2 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-06-28 US claimed
US-20040044211-A1 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2004-03-04 US claimed
EP-4066898-B1 BENZIMIDAZOLE COMPOUND OR SALT THEREOF, AGRICULTURAL AND HORTICULTURAL INSECTICIDAL AND ACARICIDAL AGENT COMPRISING SAID COMPOUND, AND METHOD FOR USING SAID INSECTICIDAL AND ACARICIDAL AGENT NIHON NOHYAKU CO LTD (JP) 2026-01-07 EP disclosed
US-20250313574-A1 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME EISAI R&D MANAGEMENT CO., LTD. (JP) 2025-10-09 US disclosed
US-12389911-B2 Benzimidazole compound or salt thereof, agricultural and horticultural insecticidal and acaricidal agent containing said compound, and method for using same NIHON NOHYAKU CO., LTD. (JP) 2025-08-19 US disclosed
EP-4536653-A2 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME Eisai R&D Management Co., Ltd. (JP) 2025-04-16 EP disclosed
CN-119775207-A Morpholine-containing amide compound and preparation method and application thereof 山东农业大学 2025-04-08 CN disclosed
US-6706911-B1 REACTING N-SUBSTITUTED 3-AMINOACRYLIC ESTERS WITH HALOALKYLCARBOXYLIC ANHYDRIDES IN PRESENCE OF BASE; PYRAZOLE-4-CARBOXYLIC ACID CHEMICAL INTERMEDIATES; HALOACYLATION BAYER AKTIENGESELLSCHAFT (DE) 2004-03-16 US disclosed
US-20040044211-A1 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2004-03-04 US disclosed
WO-2003068743-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2003-08-21 WO disclosed
CN-1045439-C New herbicides RHONE POULENC AGRICULTURE (GB) 1999-10-06 CN disclosed
CN-1104636-A New compositions of matter RHONE POULENC AGRICULTURE (FR) 1995-07-05 CN disclosed
CN-1085219-A New herbicides RHONE POULENC AGRICULTURE (GB) 1994-04-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313574-A1 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME NEU1, NEU2, NEU4 NOTUM 980/4885ASPH 555/4885HPGD 1182/4885
US-12389911-B2 Benzimidazole compound or salt thereof, agricultural and horticultural insecticidal and acaricidal agent containing said compound, and method for using same HDAC6, HDAC2, HDAC1 NOTUM 53/4885ASPH 719/4885HPGD 4069/4885
US-20040044211-A1 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them ABCB11, SLC10A1, PON1 NOTUM 2703/4885ASPH 674/4885HPGD 320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.